F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 21, 2008 | $1,604,014 | Replaced |
| 2nd Quarter - Amendment (this page) | Nov 12, 2008 | $1,640,014 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pandemic preparedness funding; Accutane safety; stockpiling of Tamiflu; reimbursement and general health issues; Early Treatment for HIV Act. Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R.2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act. Influenza Pandemic preparedness federal, state and local levels.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BARNETT New | Director, Diagnostics |
| DARIN GARDNER | Director of Federal Government Affairs |
| JAMES SCOTT | Director of Federal Government Affairs |
Veterans VET
VA standardization of purchasing policies relating to blood glucose equipment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DANIEL | Director, Diagnostics |
Medicare/Medicaid MMM
Medicare Part B and Part D coverage of and reimbursement for pharmaceuticals, including oncology, rheumatoid arthritis, ESRD, osteoporosis, diabetes, and access to influenza medications, comparative effectiveness, and possible related provisions in S.3101 and H.R. 6133, Medicare Improvements for Patients and Providers Act; H.R.6331/S.3101, Medicare Improvement for patients and Providers Act, as it pertains to the physicians quality reporting initiative; S.3118, preserving access to Medicare Act, as it pertains to the physicians quality reporting initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES SCOTT | Director, Federal Governement Affairs |
Housing HOU
Issues related Federal position on mold testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DANIEL | Director, Diagnostics |
Budget/Appropriations BUD
Issues related to government purchases of pandemic drugs; The Labor-Health and Human Services Appropriations Act for 2009 and the Supplemental Appropriations Act for 2008 provisions related to pandemic influenza; FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment; S.3181 FY09 Homeland Security Appropriations related to preparedness for pandemic influenza; FY08 Emergency Supplemental Appropriations related to preparedness for pandemic influenza.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARIN GARDNER | Director of Federal Government Affairs |
| JAMES SCOTT | Director of Federal Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.